|
US286774A
(en)
|
|
1883-10-16 |
|
Door-hanger |
|
US5700466A
(en)
|
1981-09-08 |
1997-12-23 |
The Rockefeller University |
Method of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factor
|
|
US4459359A
(en)
|
1981-11-19 |
1984-07-10 |
New York Blood Center, Inc. |
Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
|
|
US5672347A
(en)
|
1984-07-05 |
1997-09-30 |
Genentech, Inc. |
Tumor necrosis factor antagonists and their use
|
|
US4857456A
(en)
|
1985-04-30 |
1989-08-15 |
The Regents Of The University Of California |
Assay of Bone morphogenetic protein (BMP) and anti-BMP antibody for the diagnosis of bone disorders
|
|
FR2590674B1
(fr)
|
1985-11-25 |
1989-03-03 |
Inst Nat Sante Rech Med |
Nouveaux reactifs de diagnostic
|
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
|
US5223395A
(en)
|
1988-12-01 |
1993-06-29 |
Centocor, Inc. |
Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
|
|
EP0440044A1
(en)
|
1990-01-31 |
1991-08-07 |
Abbott Laboratories |
Avoidance of human anti-mouse antibody interference in in vitro diagnostic testing
|
|
US5094740A
(en)
|
1990-02-16 |
1992-03-10 |
Glycomed, Inc. |
Two-dimensional electrophoretic separation of carbohydrates
|
|
GB9028123D0
(en)
|
1990-12-28 |
1991-02-13 |
Erba Carlo Spa |
Monoclonal antibodies against human tumor necrosis factor alpha
|
|
US6284471B1
(en)
|
1991-03-18 |
2001-09-04 |
New York University Medical Center |
Anti-TNFa antibodies and assays employing anti-TNFa antibodies
|
|
US5582998A
(en)
|
1991-06-19 |
1996-12-10 |
Boehringer Ingelheim International Gmbh |
Monoclonal antibodies against human TNF-binding protein I (TNF-BP I) and immunoassays therefor
|
|
JPH0566222A
(ja)
|
1991-09-09 |
1993-03-19 |
Tosoh Corp |
物質の分析方法
|
|
ATE240394T1
(de)
|
1992-10-23 |
2003-05-15 |
Immunex Corp |
Methoden zur herstellung löslicher, oligomerer proteine
|
|
ATE199392T1
(de)
|
1992-12-04 |
2001-03-15 |
Medical Res Council |
Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
|
|
EP0642021B1
(en)
|
1993-09-07 |
2000-11-02 |
Wako Pure Chemical Industries Ltd |
Process for measuring complement activity and reagent used therefor
|
|
JPH07110331A
(ja)
|
1993-09-07 |
1995-04-25 |
Wako Pure Chem Ind Ltd |
ヒト補体価測定方法及びヒト補体価測定用試薬組成物
|
|
JPH07140144A
(ja)
*
|
1993-11-19 |
1995-06-02 |
S R L:Kk |
アレルゲン特異的ＩｇＥ抗体の測定方法および抗原抗体複合体の測定方法
|
|
DE69530107T2
(de)
|
1994-12-28 |
2003-10-16 |
University Of Kentucky, Lexington |
Monoklonaler anti-idiotypischer antikörper 3h1 aus maus
|
|
US6903183B1
(en)
|
1996-06-07 |
2005-06-07 |
Texas Tech University Health Services Center |
Compositions and methods for regulation of steroidogenesis
|
|
JP3718435B2
(ja)
|
1996-08-12 |
2005-11-24 |
積水化学工業株式会社 |
細胞機能測定用容器及び細胞機能測定方法
|
|
AU727500B2
(en)
|
1996-08-12 |
2000-12-14 |
Sekisui Kagaku Kogyo Kabushiki Kaisha |
Container for measurement of cell functions, kit for measurement of cell functions and method for measuring cell functions
|
|
US6391622B1
(en)
|
1997-04-04 |
2002-05-21 |
Caliper Technologies Corp. |
Closed-loop biochemical analyzers
|
|
US6309888B1
(en)
|
1998-09-04 |
2001-10-30 |
Leuven Research & Development Vzw |
Detection and determination of the stages of coronary artery disease
|
|
DE19858777B4
(de)
|
1998-12-18 |
2006-07-27 |
Delta Biotechnology Ltd. |
Verfahren zur teilweisen oder vollständigen Trennung von glykosilierten und nicht-glykosilierten Proteinen
|
|
US6680209B1
(en)
|
1999-12-06 |
2004-01-20 |
Biosite, Incorporated |
Human antibodies as diagnostic reagents
|
|
AU2262501A
(en)
|
1999-12-16 |
2001-06-25 |
Amgen, Inc. |
Tnfr/opg-like molecules and uses thereof
|
|
US7323552B2
(en)
|
2000-07-31 |
2008-01-29 |
The General Hospital Corporation |
Variant integrin polypeptides and uses thereof
|
|
IL155611A0
(en)
*
|
2000-11-02 |
2003-11-23 |
Molecular Discoveries L L C |
Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
|
|
EP1637601A3
(en)
|
2001-02-21 |
2006-03-29 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
|
EP1379554A2
(en)
|
2001-02-21 |
2004-01-14 |
Curagen Corporation |
Proteins, polynucleotides encoding them and methods of using the same
|
|
ATE476654T1
(de)
|
2001-03-02 |
2010-08-15 |
Activx Biosciences Inc |
Plattform für protein-profiling
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US20030040027A1
(en)
|
2001-08-16 |
2003-02-27 |
Gerd Ritter |
Method for determining protein component in a biological sample
|
|
CA2466592A1
(en)
|
2001-11-12 |
2003-05-22 |
Koen Hellendoorn |
Modified anti-tnf alpha antibody
|
|
AU2002347152A1
(en)
|
2001-12-05 |
2003-06-17 |
Cangene Corporation |
Immune globulin formulations for the treatment and prevention of an orthopoxvirus infection
|
|
GB0208817D0
(en)
|
2002-04-17 |
2002-05-29 |
European Molecular Biology Lab Embl |
Method for producing monoclonal antibodies
|
|
US20040022792A1
(en)
|
2002-06-17 |
2004-02-05 |
Ralph Klinke |
Method of stabilizing proteins at low pH
|
|
WO2004012673A2
(en)
|
2002-08-01 |
2004-02-12 |
Wyeth, |
Methods and reagents relating to inflammation and apoptosis
|
|
US20060034845A1
(en)
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
US7662569B2
(en)
|
2003-04-11 |
2010-02-16 |
Cedars-Sinai Medical Center |
Methods of assessing Crohn's disease patient phenotype by I2 serologic response
|
|
WO2005094200A2
(en)
*
|
2003-06-20 |
2005-10-13 |
University Of Florida |
Biomarkers for differentiating between type 2 and type 2 diabetes
|
|
SG145712A1
(en)
|
2003-08-01 |
2008-09-29 |
Amgen Inc |
Crystalline tumor necrosis factor receptor 2 polypeptides
|
|
CA2535804A1
(en)
|
2003-08-14 |
2005-03-03 |
Wyeth |
Anti-lewis y anti-idiotypic antibodies and uses thereof
|
|
EP1519194A1
(en)
|
2003-09-24 |
2005-03-30 |
Roche Diagnostics GmbH |
Use of gfap for identification of intracerebral hemorrhage
|
|
US7939634B2
(en)
|
2004-01-27 |
2011-05-10 |
Compugen Ltd. |
Polynucleotides encoding polypeptides and methods using same
|
|
US20090275496A1
(en)
|
2004-05-07 |
2009-11-05 |
Peptimmune, Inc. |
Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
|
|
WO2006004958A2
(en)
|
2004-06-30 |
2006-01-12 |
Centocor, Inc. |
Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
|
|
US20060253263A1
(en)
|
2005-04-11 |
2006-11-09 |
Meshkin Brian J |
Method to optimize drug selection, dosing and evaluation and to help predict therapeutic response and toxicity from immunosuppressant therapy
|
|
ATE460672T1
(de)
|
2005-05-20 |
2010-03-15 |
Genentech Inc |
Vorbehandlung einer biologischen probe aus einem individuum mit autoimmunkrankheit
|
|
ES2530265T3
(es)
|
2005-07-21 |
2015-02-27 |
Genmab A/S |
Ensayos de potencia de unión de una sustancia medicamentosa de anticuerpo a un receptor FC
|
|
EP1937307A4
(en)
|
2005-09-14 |
2009-05-13 |
Hutchinson Fred Cancer Res |
SPECIFIC REMOVAL OF ACTIVATED IMMUNOCELLS
|
|
US7542502B2
(en)
|
2005-09-27 |
2009-06-02 |
Cymer, Inc. |
Thermal-expansion tolerant, preionizer electrode for a gas discharge laser
|
|
WO2007056540A2
(en)
|
2005-11-08 |
2007-05-18 |
Medarex, Inc. |
Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
|
|
JP2007147367A
(ja)
|
2005-11-25 |
2007-06-14 |
Sekisui Chem Co Ltd |
サイトカイン産生能の測定方法
|
|
DE102005057920A1
(de)
|
2005-12-02 |
2007-06-28 |
Strohner, Pavel, Dr. |
Immunoassay zur simultanen immunchemischen Bestimmung eines Analyten (Antigen) und eines gegen den Analyten gerichteten Therapieantikörpers in Proben
|
|
EP1857559A1
(en)
*
|
2006-05-16 |
2007-11-21 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
A method for predicting responsiveness to TNF alpha blocking agents
|
|
US20100130367A1
(en)
|
2006-07-11 |
2010-05-27 |
Drexel University |
Methods of Quantitatively Assessing Inflammation with Biosensing Nanoparticles
|
|
US20080286774A1
(en)
|
2007-05-16 |
2008-11-20 |
The Regents Of The University Of California |
Real-time individualized therapy evaluation
|
|
ES2526211T3
(es)
|
2007-07-13 |
2015-01-08 |
Nestec S.A. |
Selección de fármacos para la terapia del cáncer de pulmón utilizando matrices basadas en anticuerpos
|
|
US20090035216A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Biomonitor Aps |
Method for determining in vivo biopharmaceutical concentration or bioavailability
|
|
EP2200613B1
(en)
|
2007-09-21 |
2018-09-05 |
The Johns Hopkins University |
Phenazine derivatives and uses thereof
|
|
CN101214372A
(zh)
*
|
2008-01-04 |
2008-07-09 |
中国人民解放军第四军医大学 |
一种体内诱导出针对TNF-α分子的自身抗体的蛋白疫苗的构建方法
|
|
AU2008348252A1
(en)
|
2008-01-15 |
2009-07-23 |
Stichting Sanquin Bloedvoorziening |
Method and kits for detecting antibodies against therapeutic antibodies
|
|
WO2009126380A2
(en)
|
2008-03-05 |
2009-10-15 |
Singulex, Inc. |
Methods and compositions for highly sensitive detection of molecules
|
|
NZ621655A
(en)
|
2009-10-26 |
2015-08-28 |
Nestec Sa |
Assays for the detection of anti-tnf drugs and autoantibodies
|
|
JP5066222B2
(ja)
|
2010-05-31 |
2012-11-07 |
三菱電機株式会社 |
ネットワーク解析支援装置、ネットワーク解析支援方法及びプログラム
|
|
JP6173911B2
(ja)
|
2010-09-10 |
2017-08-09 |
メディミューン リミテド |
抗体誘導体
|
|
NZ609363A
(en)
|
2010-10-18 |
2015-04-24 |
Nestec Sa |
Methods for determining anti-drug antibody isotypes
|
|
DK2676137T3
(en)
|
2011-02-17 |
2015-01-19 |
Nestec Sa |
TESTS TO DETECT AUTO ANTIBODIES FOR ANTI-TNF PHARMACEUTICALS
|
|
DK3311834T3
(da)
|
2011-05-02 |
2026-04-20 |
Millennium Pharmaceuticals Inc |
Formulering til anti-alfa4beta7-antistof
|
|
CN103619874A
(zh)
|
2011-06-30 |
2014-03-05 |
株式会社免疫生物研究所 |
可溶性整联蛋白α4突变体
|
|
MX343324B
(es)
|
2011-07-06 |
2016-11-01 |
Nestec Sa |
Ensayos para detectar auto anticuerpos neutralizadores de la terapia biologica con tnf alpha.
|
|
US20130266963A1
(en)
|
2011-07-06 |
2013-10-10 |
Nestec S.A. |
Assay for detecting neutralizing autoantibodies to biologic therapy
|
|
US20140051184A1
(en)
|
2012-08-15 |
2014-02-20 |
Nestec S.A. |
Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies thereto
|
|
US20130295685A1
(en)
|
2012-04-10 |
2013-11-07 |
Nestec S.A. |
Mobility shift assays for detecting anti-tnf alpha drugs and autoantibodies
|
|
BR112015012482A2
(pt)
|
2012-11-30 |
2017-07-11 |
Nestec Sa |
ensaios para detecção de autoanticorpos neutralizantes à terapia com produtos biológicos
|
|
MX388027B
(es)
|
2013-11-13 |
2025-03-19 |
Pfizer |
Anticuerpos específicos para el ligando 1a tipo factor de necrosis tumoral y composiciones y usos de los mismos.
|
|
WO2016088104A2
(en)
|
2014-12-05 |
2016-06-09 |
Nestec S.A. |
Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
|
|
KR102423893B1
(ko)
|
2015-03-31 |
2022-07-21 |
삼성디스플레이 주식회사 |
플렉서블 표시 장치
|
|
EP3554342B1
(en)
|
2016-12-14 |
2024-07-24 |
Biora Therapeutics, Inc. |
Treatment of a disease of the gastrointestinal tract with a tnf inhibitor
|